Microdosing THC means taking a few milligrams of cannabis's main mind-altering compound to seek subtle benefits without feeling high. The supporting evidence is thin and uneven: low oral doses are clearly better tolerated than recreational amounts, but benefits for sleep, stress, and pain are modest and inconsistent. Some people should avoid it entirely. (Full Review)

Protocol

Starting Dose

1–2.5 mg oral

A "start low, go slow" approach, with titration up by ~1 mg only after several days; older adults start at 1–1.5 mg.

Timing

1–2 h before bed

For sleep, align oral onset with sleep onset; for daytime mood or pain, a single small morning or midday dose.

Frequency

Single dose, avoid daily

One small dose per occasion, with tolerance breaks (e.g., a few days on, several off) to preserve effect.

Time to effect

Oral onset

30 min – 2 h

Preferred route for precise microdosing despite the delay.

Oral duration

4–8 h

Effects can last several hours; oral peak can be 2–4 h after dosing.

Inhaled onset

Within minutes

Acts fast but far harder to dose precisely.

Benefits

Medium: Better tolerability than standard doses

Low: Sleep onset and quality; anxiety and stress reduction; pain modulation; appetite stimulation

Speculative: Neuroprotection and healthy brain aging; anti-inflammatory and endocannabinoid tone support

Contraindications

Personal or family history of psychosis or schizophrenia

Pregnancy or breastfeeding

Adolescents and young adults under ~25

Recent cardiovascular events (heart attack <90 days, unstable angina)

History of cannabis use disorder

Key Interactions

CYP2C9 and CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir, fluconazole)

CNS depressants: benzodiazepines (diazepam, lorazepam), opioids (oxycodone, morphine)

Anticoagulants (warfarin, apixaban)

Sedating antihistamines (diphenhydramine, doxylamine) and alcohol-containing products

Sedative or calming supplements (melatonin, valerian, kava, high-dose magnesium)

CBD

Alcohol

Risk & Side Effects

High: Psychoactive impairment and intoxication; driving and operational safety risk

Medium: Anxiety, paranoia, and dysphoria; tolerance and loss of effect

Low: Cardiovascular effects; cannabis use disorder and dependence

Speculative: Long-term cognitive and brain effects; drug interaction amplification at low doses

Monitoring

Marker	Target	Why
Resting heart rate	50–70 bpm	THC acutely raises heart rate; baseline detects sensitivity
Blood pressure	<120/80 mmHg	THC can cause transient changes including orthostatic drops
Liver enzymes (ALT, AST)	ALT <25 U/L (men), <20 U/L (women)	THC is liver-metabolized; relevant with co-medications

Cadence: Reassess at ~1–2 weeks after starting, then periodically (every few months) if use continues.

Qualitative Assessment

Sleep quality: easier sleep onset and subjective restfulness without next-day grogginess
Mood and anxiety: reduced everyday stress reactivity without any sense of being "high," paranoid, or dysphoric
Cognitive clarity: no detectable impairment in focus, memory, or reaction time
Absence of intoxication: benefit with no perceptible high, confirming the dose is genuinely a microdose

Microdosing THC for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment